Omphalitis Hospitalizations at a US Children's Hospital

Hosp Pediatr. 2022 Dec 1;12(12):e423-e427. doi: 10.1542/hpeds.2022-006623.

Abstract

Objectives: To describe demographics, presentation, resource use, and outcomes of patients diagnosed with omphalitis.

Methods: This was a retrospective descriptive study of infants with omphalitis at a children's hospital system between January 2006 and December 2020. Presentation, resource use, and outcomes (omphalitis complications [eg, necrotizing fasciitis], 30-day related cause revisit, and death) were described.

Results: Ninety-one patients had a primary or secondary International Classification of Diseases, Ninth or 10th Revision, code for omphalitis. Seventy-eight patients were included in analysis (47 with omphalitis as primary reason for admission). Patients with omphalitis as the primary reason for admission presented with rash (44 of 47, 93.6%), fussiness/irritability (19 of 47, 40.4%), and fever (6 of 47, 12.8%). C-reactive protein was minimally elevated, with a median of 0.4 mg/dL (interquartile range 0.29-0.85).Among all patients, blood cultures were positive in 3 (3 of 78, 3.8%) and most had positive wound cultures (70 of 78, 89.7%), with primarily gram-positive organisms. Median duration of intravenous antibiotics was 5 days (interquartile range 3-7). No patients had complications of omphalitis or death. Five patients (5 of 78, 6.4%) had a 30-day revisit for a related cause.

Conclusions: We found variation in presentation and management of patients with omphalitis at our tertiary children's hospital system. Wound cultures, but not blood tests, were helpful in guiding management in the majority of cases. There were no complications of omphalitis or deaths.

MeSH terms

  • Child
  • Chorioamnionitis*
  • Female
  • Hospitalization
  • Hospitals, Pediatric
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Inflammation / complications
  • Retrospective Studies
  • Soft Tissue Infections*